|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Psychotic Disorder | |||||
| Schizoaffective Disorder | |||||
| Schizophrenia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| Psychotic Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Mental Disorders | |||||
| Pathologic Processes | |||||
| Schizophrenia and Disorders with Psychotic Features | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||